Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Army
Cantor Fitzgerald
Daiichi Sankyo

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,405,084

« Back to Dashboard

Summary for Patent: 5,405,084

Title: Nozzle assembly for preventing back-flow
Abstract:A nozzle assembly which comprises a nozzle aperture for discharge of a fluid as a spray of droplets, and a conduit in fluid flow communication with the nozzle aperture. The flow of fluid through the conduit is restricted by the minimum effective cross-sectional area of the conduit transverse to the line of flow of fluid through the conduit so that back flow of fluid from the nozzle aperture through the conduit at ambient and operational pressure differentials is substantially prevented. The invention further provides for a method of discharging a fluid as a spray of droplets, and a spray generating device which includes the nozzle assembly of the present invention.
Inventor(s): Weston; Terence E. (Stradbroke, GB2), Dunne; Stephen T. (Ipswich, GB2)
Assignee: DMW (Technology) Limited (GB)
Application Number:08/070,306
Patent Claim Types:
see list of patent claims
Device; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,405,084

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9026298Dec 04, 1990
United Kingdom9109072Apr 26, 1991
PCT Information
PCT FiledDecember 04, 1991PCT Application Number:PCT/GB91/02147
PCT Publication Date:June 25, 1992PCT Publication Number: WO92/10306

International Patent Family for Patent: 5,405,084

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria134165► Subscribe
Australia659618► Subscribe
Australia8942391► Subscribe
Canada2097700► Subscribe
Germany69117193► Subscribe
Denmark0560858► Subscribe
European Patent Office0560858► Subscribe
Spain2083726► Subscribe
United Kingdom9026298► Subscribe
United Kingdom9109072► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Cantor Fitzgerald
Daiichi Sankyo
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus